Breanna Taylor, PharmD, BCOP

home / authors / breanna-taylor-pharmd-bcop

Articles

Updates in the Management of Transplant-Ineligible Patients With Multiple Myeloma

Updates in the Management of Transplant-Ineligible Patients With Multiple Myeloma

Breanna Taylor, PharmD, BCOP
May 1st 2025

Explore the latest advancements in treating transplant-ineligible multiple myeloma, highlighting new therapies and clinical trial outcomes for improved patient care.

Read More

A Review of Axatilimab in Steroid Refractory Chronic Graft versus Host Disease

A Review of Axatilimab in Steroid Refractory Chronic Graft versus Host Disease

Breanna Taylor, PharmD, BCOP
January 27th 2025

Axatilimab-csfr is a colony-stimulating factor-1 receptor (CSFR1) blocking monoclonal antibody indicated for cGVHD after 2 or more lines of prior therapy in adults and pediatric patients that weigh at least 40 kg.

Read More

Latest Updated Articles

Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com
Published: March 10th 2025 | Updated: March 21st 2025
Pharmacists Will Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM
Image credit: toeytoey | stock.adobe.com
Published: March 12th 2025 | Updated: March 18th 2025
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
Blood test for graft-vs-host-disease (GVHD) -- Image credit: MdBabul | stock.adobe.com
Published: February 26th 2025 | Updated: March 14th 2025
Navigating Steroid-Refractory GVHD Treatment: A Pharmacist’s Guide to Medication Management
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Published: March 7th 2025 | Updated: March 10th 2025
FDA Approves Interchangeable Biosimilar to Xolair
Benjamin Franklin on US dollar surrounded by pills | Image Credit: © Cagkan - stock.adobe.com
Published: January 22nd 2025 | Updated: January 28th 2025
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms